Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q by Adema, V, Palomo, L, Walter, W, Mallo, M, Hutter, S, La Framboise, T, Arenillas, L, Meggendorfer, M, Radivoyevitch, T, Xicoy, B, Pellagatti, A, Haferlach, C, Boultwood, J, Kern, W, Visconte, V, Sekeres, M, Barnard, J, Haferlach, T, Solé, F, Maciejewski, JP

Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis by McGraw, KL, Cheng, C-H, Chen, YA, Hou, H-A, Nilsson, B, Genovese, G, Cluzeau, T, Pellagatti, A, Przychodzen, BP, Mallo, M, Arenillas, L, Mohamedali, A, Adès, L, Sallman, DA, Padron, E, Sokol, L, Moreilhon, C, Raynaud, S, Tien, H-F, Boultwood, J, Ebert, BL, Sole, F, Fenaux, P, Mufti, GJ, Maciejewski, JP

CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies by Bueno, C, Barrena, S, Bataller, A, Ortiz-Maldonado, V, Elliott, N, O'Byrne, S, Wang, G, Rovira, M, Gutierrez-Agüera, F, Trincado, JL, Gonzalez, M, Morgades, M, Sorigué, M, Barcena, P, Zanetti, SR, Torrebadell, M, Vega-García, N, Rives, S, Mallo, M, Sole, F, Mead, AJ, Roberts, I, Thongjuea, S, Psaila, B, Juan, M, Delgado, J, Urbano-Ispizua, Á, Ribera, J-M, Orfao, A, Roy, A, Menéndez, P